Vaccine Development
New Tool ID's CD4+ T-Cell Antigens
Published in Vaccine Weekly, July 12th, 1999
As these so-called T-helper cells are the basis of cell-mediated immunity, the technique promises to revolutionize the discovery process for antitumor and antiviral vaccines as well as the diagnosis of autoimmune diseases.
"This genetic approach is generally applicable to the identification of autoantigens, mutated and xenogeneic antigens recognized by CD4+ T cells derived from patients with cancer, autoimmune diseases, or infectious diseases, and may be useful for the development of preventive and therapeutic vaccines," wrote Rong-Fu Wang and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1999-07-12)
More Articles from Vaccine Weekly
- AIDS Vaccines
Highly Attenuated SIV Protects Against Vaginal Challenge - Cancer Vaccines
Globo H Safe in Phase I Prostate Cancer Trial - Conference Coverage (ASCO)
Active Specific Immunotherapy Mediates Tumor Regression - Immunization
Hepatitis Vaccine Guidelines Aren't Being Followed - Immunization (HBV)
Annual Vaccination Schedule is Efficacious - Virology (HBV)
T-Cell Response May Control Viremia During Vaccine Therapy - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
